These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 33374094)
101. Basal and bolus insulin requirements in children, adolescents, and young adults with type 1 diabetes mellitus on continuous subcutaneous insulin infusion (CSII): effects of age and puberty. Cemeroglu AP; Thomas JP; Zande LT; Nguyen NT; Wood MA; Kleis L; Davis AT Endocr Pract; 2013; 19(5):805-11. PubMed ID: 23757622 [TBL] [Abstract][Full Text] [Related]
102. Insulin doses before and one year after pump start: children have a reversed dawn phenomenon. Nicolajsen T; Samuelsson A; Hanas R J Diabetes Sci Technol; 2012 May; 6(3):589-94. PubMed ID: 22768890 [TBL] [Abstract][Full Text] [Related]
103. Development of optimal kids insulin dosing system formulas for young children with type 1 diabetes mellitus. Alemzadeh R; Hoffmann RG; Dasgupta M; Parton E Diabetes Technol Ther; 2012 May; 14(5):418-22. PubMed ID: 22239470 [TBL] [Abstract][Full Text] [Related]
104. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Bachran R; Beyer P; Klinkert C; Heidtmann B; Rosenbauer J; Holl RW; ; ; Pediatr Diabetes; 2012 Feb; 13(1):1-5. PubMed ID: 21545675 [TBL] [Abstract][Full Text] [Related]
105. NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidance. Pickup JC; Hammond P Diabet Med; 2009 Jan; 26(1):1-4. PubMed ID: 19125753 [No Abstract] [Full Text] [Related]
106. The use of insulin pump therapy in the pediatric age group. Shalitin S; Phillip M Horm Res; 2008; 70(1):14-21. PubMed ID: 18493145 [TBL] [Abstract][Full Text] [Related]
107. Continuous subcutaneous insulin infusion therapy: effects on quality of life. Scheidegger U; Allemann S; Scheidegger K; Diem P Swiss Med Wkly; 2007 Aug; 137(33-34):476-82. PubMed ID: 17990132 [TBL] [Abstract][Full Text] [Related]
108. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Klinkert C; Bachran R; Heidtmann B; Grabert M; Holl RW; Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):118-22. PubMed ID: 17973210 [TBL] [Abstract][Full Text] [Related]
109. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus. Rabbone I; Bobbio A; Berger K; Trada M; Sacchetti C; Cerutti F J Endocrinol Invest; 2007 Jun; 30(6):477-83. PubMed ID: 17646722 [TBL] [Abstract][Full Text] [Related]
110. Use of insulin pump therapy in the pediatric age-group: consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Phillip M; Battelino T; Rodriguez H; Danne T; Kaufman F; ; ; ; ; Diabetes Care; 2007 Jun; 30(6):1653-62. PubMed ID: 17372151 [No Abstract] [Full Text] [Related]
111. Current practice of insulin pump therapy in children and adolescents - the Hannover recipe. Danne T; von Schütz W; Lange K; Nestoris C; Datz N; Kordonouri O Pediatr Diabetes; 2006 Aug; 7 Suppl 4():25-31. PubMed ID: 16774615 [TBL] [Abstract][Full Text] [Related]
112. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387 [TBL] [Abstract][Full Text] [Related]
113. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Scheiner G; Boyer BA Diabetes Res Clin Pract; 2005 Jul; 69(1):14-21. PubMed ID: 15955383 [TBL] [Abstract][Full Text] [Related]
114. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227 [TBL] [Abstract][Full Text] [Related]
115. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Ahern JA; Boland EA; Doane R; Ahern JJ; Rose P; Vincent M; Tamborlane WV Pediatr Diabetes; 2002 Mar; 3(1):10-5. PubMed ID: 15016169 [TBL] [Abstract][Full Text] [Related]
116. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. Litton J; Rice A; Friedman N; Oden J; Lee MM; Freemark M J Pediatr; 2002 Oct; 141(4):490-5. PubMed ID: 12378187 [TBL] [Abstract][Full Text] [Related]
117. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Hanas R Horm Res; 2002; 57 Suppl 1():101-4. PubMed ID: 11979036 [TBL] [Abstract][Full Text] [Related]
118. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents. Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094 [TBL] [Abstract][Full Text] [Related]
119. Insulin pump treatment in children and adolescents with type 1 diabetes. Hofer S; Meraner D; Koehle J Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614 [TBL] [Abstract][Full Text] [Related]
120. [Insulin pump therapy in children and teenagers]. Bergholtz CH; Olsen B; Johannesen J Ugeskr Laeger; 2009 Jun; 171(23):1913-8. PubMed ID: 19500513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]